Introduction: End-stage renal disease patients have impaired health-related quality of life as compared to the general population due to the combined effects of the disease and hemodialysis (HD) therapy. As a result, poor quality of life increases their risk of mortality and hospitalization and affects their general well-being. While existing rehabilitation programs aim to improve physical activity in HD patients, the link between work status, particularly within the first year of treatment, and their quality of life remains unclear.
Objectives: This study aimed to compare the quality of life of working and nonworking end-stage renal disease patients during their first year of HD.
Materials And Methods: The comparative cross-sectional study involved 120 patients (60 working, 60 non- working) with end-stage renal disease at the hemodialysis (HD) centers during their first year of HD. Patients were administered the SF-36 survey to determine their physical and mental health levels. Statistical analyses, including Mann-Whitney U tests, Spearman's correlation, and multiple regression, were performed using SPSS 22.
Results: Employed patients demonstrated significantly higher physical functioning (MR = 82.37, Me = 41.27) and mental health (MR = 74.33, Me = 47.22) scores compared to non-employed (MR = 38,63, Me = 29.07 and MR = 46.67, Me = 38,14, respectively) (p < 0.001). Employment is a significant predictor of high quality of life (B = 11.6 for PF, B = 6.5 for MH). Despite older age and increased prevalence of comorbidities, employed patients demonstrate better quality of life results.
Conclusion: Employment has a positive effect on the quality of life of patients with chronic renal failure receiving HD, indicating that their regimen may be improved by incorporating work into the treatment program. Employment opportunities for patients with chronic renal failure receiving dialysis should be explored in the future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/hdi.13221 | DOI Listing |
JMIR Res Protoc
March 2025
Paseo de los Encomendadores, Faculty of Health Sciences, University of Burgos, Burgos, Spain.
Background: Breast cancer is the second most common cancer in women worldwide. Treatments for this disease often result in side effects such as pain, fatigue, loss of muscle mass, and reduced quality of life. Physical exercise has been shown to effectively mitigate these side effects and improve the quality of life in patients with breast cancer.
View Article and Find Full Text PDFRes Aging
March 2025
Labour Institute for Economic Research LABORE, IZA Institute of Labor Economics, University of Jyväskylä, Helsinki, Finland.
Ageing populations foreground understanding how retirement affects quality of life. The inconclusive findings on retirement's quality of life impacts encourage further analyses of this association's complexity. Using waves 4 (2011) and 6 (2015) of the Survey of Health, Ageing and Retirement in Europe ( = 9249) and conditional change multilevel mixed-effects linear regressions, this study investigates how changes in three measures of social network involvement (size of close social network, frequency of contact with one's close social network, and emotional closeness with one's close social network) moderate how retirement is associated with quality of life.
View Article and Find Full Text PDFFood Addit Contam Part A Chem Anal Control Expo Risk Assess
March 2025
Food Toxicology and Contaminants Department, National Research Centre, Giza, Egypt.
Citrus fruits, known for their vibrant flavours and health benefits, are susceptible to fungal attacks, particularly from toxigenic fungi, which pose a significant pre- and post-harvest hazard. However, aromatic oils and their nanoparticles may effectively address this issue. Marjoram and fennel oils, alongside their nanoparticles, were extracted, and their aromatic constituents and antimicrobial activities were evaluated.
View Article and Find Full Text PDFEuropace
March 2025
Clinical Cardiac Academic Group, Genetic and Cardiovascular Sciences Institute, City-St George's University of London, London, UK.
Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!